These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7783128)

  • 21. Synthesis and biological activity of spirocyclic benzopyran imidazolone potassium channel openers.
    Gadwood RC; Kamdar BV; Dubray LA; Wolfe ML; Smith MP; Watt W; Mizsak SA; Groppi VE
    J Med Chem; 1993 May; 36(10):1480-7. PubMed ID: 8496916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel anti-ischemic ATP-sensitive potassium channel (K(ATP)) opener without vasorelaxation: N-(6-aminobenzopyranyl)-N'-benzyl-N' '-cyanoguanidine analogue.
    Yoo SE; Yi KY; Lee S; Suh J; Kim N; Lee BH; Seo HW; Kim SO; Lee DH; Lim H; Shin HS
    J Med Chem; 2001 Nov; 44(24):4207-15. PubMed ID: 11708922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 6-Sulfonylchromenes as highly potent K(ATP)-channel openers.
    Salamon E; Mannhold R; Weber H; Lemoine H; Frank W
    J Med Chem; 2002 Feb; 45(5):1086-97. PubMed ID: 11855989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminothiocarbonylamino)-2H-1-benzopyrans structurally related to (+/-)-cromakalim as tissue-selective pancreatic beta-cell K(ATP) channel openers.
    Sebille S; de Tullio P; Florence X; Becker B; Antoine MH; Michaux C; Wouters J; Pirotte B; Lebrun P
    Bioorg Med Chem; 2008 May; 16(10):5704-19. PubMed ID: 18406154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.
    Yanagisawa T; Teshigawara T; Taira N
    Br J Pharmacol; 1990 Sep; 101(1):157-65. PubMed ID: 2149290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of rubidium on responses to potassium channel openers in rat isolated aorta.
    Greenwood IA; Weston AH
    Br J Pharmacol; 1993 Aug; 109(4):925-32. PubMed ID: 8401946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two types of ATP-sensitive potassium channels in rat portal vein smooth muscle cells.
    Zhang HL; Bolton TB
    Br J Pharmacol; 1996 May; 118(1):105-14. PubMed ID: 8733582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potassium channel activators based on the benzopyran substructure: synthesis and activity of the C-8 substituent.
    Thompson R; Doggrell S; Hoberg JO
    Bioorg Med Chem; 2003 Apr; 11(8):1663-8. PubMed ID: 12659752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of the alkylsulfonylamino substituent located at the 6-position of 2,2-dimethylchromans structurally related to cromakalim: from potassium channel openers to calcium entry blockers?
    Florence X; Desvaux V; Goffin E; de Tullio P; Pirotte B; Lebrun P
    Eur J Med Chem; 2014 Jun; 80():36-46. PubMed ID: 24763361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic and cardiac effects of BMS-180448, a novel K+ATP opener, in anesthetized dogs and isolated rat hearts.
    D'Alonzo AJ; Grover GJ; Darbenzio RB; Sewter JC; Hess TA; Dzwonczyk S; Sleph PG
    Pharmacology; 1996 Feb; 52(2):101-12. PubMed ID: 8851631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATP-sensitive potassium channels and skeletal muscle function in vitro.
    Weselcouch EO; Sargent C; Wilde MW; Smith MA
    J Pharmacol Exp Ther; 1993 Oct; 267(1):410-6. PubMed ID: 8229769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of ATP-sensitive K+ channels by ATP and nucleotide diphosphate in rabbit portal vein.
    Kamouchi M; Kitamura K
    Am J Physiol; 1994 May; 266(5 Pt 2):H1687-98. PubMed ID: 8203568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
    Tosaki A; Hellegouarch A
    J Am Coll Cardiol; 1994 Feb; 23(2):487-96. PubMed ID: 8294705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and vasorelaxant activity of 2-fluoromethylbenzopyran potassium channel openers.
    Takahashi T; Koga H; Sato H; Ishizawa T; Taka N; Imagawa J
    Bioorg Med Chem; 1998 Mar; 6(3):323-37. PubMed ID: 9568286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New benzopyran-based openers of the mitochondrial ATP-sensitive potassium channel with potent anti-ischemic properties.
    Breschi MC; Calderone V; Martelli A; Minutolo F; Rapposelli S; Testai L; Tonelli F; Balsamo A
    J Med Chem; 2006 Dec; 49(26):7600-2. PubMed ID: 17181142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists.
    McPherson GA; Angus JA
    Br J Pharmacol; 1990 Jun; 100(2):201-6. PubMed ID: 2116201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardioprotection in ischemic rat hearts with the SH-containing angiotensin-converting enzyme inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channel.
    Sargent CA; Sleph PG; Dzwonczyk S; Smith MA; Normandin D; Antonaccio MJ; Grover GJ
    J Pharmacol Exp Ther; 1993 May; 265(2):609-18. PubMed ID: 8496812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do potassium channel openers compete with ATP to activate ATP sensitive potassium channels?
    Henry P; Escande D
    Cardiovasc Res; 1994 Jun; 28(6):754-9. PubMed ID: 7923275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization.
    Gopalakrishnan M; Buckner SA; Whiteaker KL; Shieh CC; Molinari EJ; Milicic I; Daza AV; Davis-Taber R; Scott VE; Sellers D; Chess-Williams R; Chapple CR; Liu Y; Liu D; Brioni JD; Sullivan JP; Williams M; Carroll WA; Coghlan MJ
    J Pharmacol Exp Ther; 2002 Oct; 303(1):379-86. PubMed ID: 12235274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity.
    Butera JA; Antane MM; Antane SA; Argentieri TM; Freeden C; Graceffa RF; Hirth BH; Jenkins D; Lennox JR; Matelan E; Norton NW; Quagliato D; Sheldon JH; Spinelli W; Warga D; Wojdan A; Woods M
    J Med Chem; 2000 Mar; 43(6):1187-202. PubMed ID: 10737752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.